Raia Drogasil S.A.
RADLY
$3.62
-$0.07-1.90%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 2.02B | 2.24B | 2.07B | 1.91B | 1.58B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.02B | 2.24B | 2.07B | 1.91B | 1.58B |
| Cost of Revenue | 1.37B | 1.58B | 1.46B | 1.35B | 1.10B |
| Gross Profit | 647.43M | 660.12M | 608.91M | 564.86M | 482.10M |
| SG&A Expenses | 523.62M | 521.67M | 474.21M | 437.91M | 404.44M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 36.78M | -- | -- | 166.80K | -4.49M |
| Total Operating Expenses | 1.93B | 2.10B | 1.93B | 1.78B | 1.50B |
| Operating Income | 87.03M | 138.45M | 134.70M | 126.78M | 82.15M |
| Income Before Tax | 24.19M | 56.14M | 100.00M | 70.57M | 28.27M |
| Income Tax Expenses | -3.90M | 2.34M | 15.22M | 3.00M | 3.96M |
| Earnings from Continuing Operations | 28.09M | 53.80M | 84.78M | 67.58M | 24.31M |
| Earnings from Discontinued Operations | 2.23M | -- | -- | -- | 3.89M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | 2.66M | -1.42M | -1.58M | -190.00K |
| Net Income | 30.32M | 56.46M | 83.37M | 66.00M | 28.01M |
| EBIT | 87.03M | 138.45M | 134.70M | 126.78M | 82.15M |
| EBITDA | 126.45M | 188.37M | 169.12M | 162.56M | 114.25M |
| EPS Basic | 0.02 | 0.04 | 0.05 | 0.04 | 0.02 |
| Normalized Basic EPS | 0.01 | 0.03 | 0.03 | 0.03 | 0.01 |
| EPS Diluted | 0.02 | 0.04 | 0.05 | 0.04 | 0.02 |
| Normalized Diluted EPS | 0.01 | 0.03 | 0.03 | 0.03 | 0.01 |
| Average Basic Shares Outstanding | 1.65B | 1.55B | 1.68B | 1.68B | 1.68B |
| Average Diluted Shares Outstanding | 1.69B | 1.55B | 1.69B | 1.69B | 1.69B |
| Dividend Per Share | -- | 0.03 | 0.01 | 0.01 | 0.01 |
| Payout Ratio | 0.31% | 112.92% | 0.02% | 82.42% | 0.06% |